48
Views
6
CrossRef citations to date
0
Altmetric
CONFERENCE PROCEEDINGS

Diet and individuality in detoxification

, &
Pages 95-105 | Published online: 13 Jul 2009

References

  • Kim H., Yoon Y. J., Shon J. H., Cha I. J., Shin J. G., Liu K. H. Inhibitory effects of fruit juices on CYP3A activity. Drug Metab Dispos 2006; 34: 521–523
  • Arbuthnot J. An essay concerning the nature of ailments, 3rd ed. J. Tonson pub, London 1735; 64
  • Johnson S. Dictionary of the English Language Vol 1, 1st ed. W. Strahan Ltd, London 1755
  • Tressl R., Holzer M., Apetz M. Formation of flavour components in asparagus. J Agric Food Chem 1977; 25: 455–463
  • Waring R. H., Mitchell S. C., Fenwick G. R. The chemical nature of the urinary odour produced by man after asparagus ingestion. Xenobiotica 1987; 17: 1363–1371
  • Mitchell S. C., Waring R. H., Land D., Thorpe W. V. Odorous urine following asparagus ingestion in man. Experientia 1987; 43: 382–383
  • Turner F., Smith G., Sachse C., Lightfoot T., Garner R. C., Wolf C. R., Forman D., Bishop D. T., Barrett J. H. Vegetable, fruit and meat consumption and potential risk modifying genes in relation to colorectal cancer. Int J Cancer 2004; 112: 259–264
  • MCMJ Stroombergen. Toxicological aspects of glutathione and glutathione‐S‐transferase. 1997, PhD Thesis, University of Birmingham
  • Awasthi Y. C., Sharma R., Singhal S. S. Human glutathione‐S‐transferases. Int J Biochem 1994; 26: 295–308
  • Moon Y. J., Wang X., Morris M. E. Dietary flavonoids: Effects on xenobiotic and carcinogen metabolism. Toxicol In Vitro 2006; 20: 187–210
  • Mandlekar S., Hong J. L., Kong A. N. Modulation of metabolic enzymes by dietary phytochemicals: a review of mechanisms underlying beneficial versus unfavorable effects. Curr Drug Metab 2006; 7: 661–675
  • Habig W. H., Jakoby W. B. Assays for differentiation of glutathione‐S‐transferases. Meth Enzymol 1981; 77: 398–405
  • Alam Z., Coombes N., Waring R. H., Williams A. C., Steventon G. B. Platelet sulphotransferase activity, plasma sulphate levels and sulphation capacity in patients with migraine and tension headache. Cephalalgia 1997; 17: 761–764
  • Marazzitti D., Bonuccelli U., Nuti A., Toni C., Pedri S., Palego L., Pavese N., Lucetti C., Muratorio A., Cassano G. B. Platelet 3H‐imipramine binding and sulphotransferase activity in primary headache. Cephalalgia 1994; 14: 210–214
  • Millichip J. G., Yee M. M. The diet factor in pediatric and adolescent migraine. Pediatr Neurol 2003; 28: 9–15
  • Ghazali R. A., Waring R. H. The effects of flavonoids on human phenolsulphotransferases; potential in drug metabolism and chemoprevention. Life Sci 1999; 65: 1625–1632
  • Harris R. M., Waring R. H. Dietary modulation of human phenolsulphotransferase activity. Xenobiotica 1996; 12: 1241–1247
  • Grant E. C. Food allergies and migraine. Lancet 1979; 1: 966–969
  • Harris R. M., Wood D. M., Blagg S., Owen K., Hughes P. J., Waring R. H., Kirk C. J. Phytoestrogens are potent inhibitors of oestrogen sulphation: Implications for breast cancer risk and treatment. J Clin Endocrinol Metab 2004; 89: 1779–1787
  • Waring R. H., Ayers S., Gesche A. J., Glatt H‐R., Meinl W., Jarratt P., Kirk C. J., Pettitt T., Rea D., Harris R. M. Phyto‐ and xeno‐estrogens: The contribution of diet and the environment to endocrine disruption. J Steroid Biochem Mol Biol. (in press)
  • Dawson P. A., Markovich D. Pathogenetics of the human SLC26 transporters. Curr Med Chem 2005; 12: 385–396
  • Davies E., Tsang C‐W., Ghazali A. R., Harris R. M., Waring R. H. Effects of culture with TNF‐alpha, TGF‐beta and insulin on sulphotransferase (SULT 1A1 and 1A3) activity in human colon and neuronal cell lines. Toxicol In Vitro 2004; 18: 749–754
  • Dawson P. A., Markovich D. Pathogenetics of the human SLC26 transporters. Curr Med Chem 2005; 12: 385–396
  • Parsons R. B., Waring R. H., Williams A. C., Ramsden D. B. Cysteine dioxygenase: Regional localisation of protein and mRNA in rat brain. J Neurosci Res 2001; 65: 78–84
  • Klovrza L. V. Sulphur metabolism in clinical disease., 2006 PhD Thesis, University of Birmingham
  • Wilkinson L. J., Waring R. H. Cysteine dioxygenase; modulation of expression in human cell lines by cytokines with control of sulphate formation. Toxicol In Vitro 2002; 16: 481–483
  • Bradley H., Gough A., Sokhi R. S., Hassell A., Waring R. H., Emery P. Sulphate metabolism is abnormal in patients with rheumatoid arthritis: Confirmation by in vivo biochemical findings. J Rheumatol 1994; 21: 1192–1196
  • Caramaschi P., Biasi D., Colombatti M., Pieropan S., Martinelli N., Carletto A., Volpe A., Pacor L. M., Bambara L. M. Anti‐TNF alpha therapy in rheumatoid arthritis and autoimmunity. Rheumatol Int 2006; 26: 209–214
  • Nakamura K., Honda K., Mizutani T., Akiho H., Harada N. Novel strategies for the treatment of inflammatory bowel disease: Selective inhibition of cytokines and adhesion molecules. World J Gastroenterol 2006; 12: 4628–4635
  • Holgate S. T. Cytokine and anti‐cytokine therapy for the treatment of asthma and allergic disease. Cytokine 2004; 28: 152–157
  • Bradford M. M. A rapid and sensitive method for the quantification of microgram quantities of protein utilising the principle of protein‐dye binding. Anal Biochem 1976; 72: 248–254
  • Johnston J. B., Murray K., Cain R. B. Microbial metabolism of aryl sulphonates: A re‐assessment of colorimetric methods for the determination of sulphite and their use in measuring desulphonation of aryl and alkylbenzene sulphonates. Antonie van Leeuwenhoek 1975; 41: 493–511
  • Jackson S. G., McCandless E. L. Simple rapid turbidometric determination of inorganic sulfate and/or protein. Anal Biochem 1978; 90: 802–805
  • Bradley H., Waring R. H., Emery P., Arthur V. Metabolism of low dose paracetamol in patients with rheumatoid arthritis. Xenobiotica 1991; 21: 689–693
  • Waring R. H., Harris R. M. Sulphation and gut function in autistic spectrum disorders: The potential role of nutrition. The Nutrition Practitioner 2005; 6: 1–10
  • Ramsden D. B., Parsons R. B., Ho S. L., Xie T., Waring R. H., Williams A. C. Further studies in xenbiotic metabolism and Parkinson's disease. Adv Neurol 2001; 86: 105–113

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.